Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-27 4:29 pm Sale | 2023-12-27 | 13D | NuCana plc NCNA | Sofinnova Venture Partners VIII L.P. | 251,336 11.900% | -71,915 (-22.25%) | Filing History |
| 2023-02-03 7:26 pm Unchanged | 2022-12-09 | 13D | OBSEVA SA COM OBSVF | Sofinnova Venture Partners VIII L.P. | 4,749,623 4.700% | 0 (Unchanged) | Filing History |
| 2022-02-25 7:39 pm Sale | 2021-11-23 | 13D | OBSEVA SA COM OBSVF | Sofinnova Venture Partners VIII L.P. | 4,749,623 6.100% | -96,006 (-1.98%) | Filing History |
| 2022-02-25 7:34 pm Purchase | 2021-11-18 | 13D | NuCana plc NCNA | Sofinnova Venture Partners VIII L.P. | 323,250 15.500% | 1,420 (+0.44%) | Filing History |
| 2021-03-04 06:13 am Purchase | 2020-11-05 | 13D | OBSEVA SA COM OBSVF | Sofinnova Venture Partners VIII L.P. | 4,845,629 8.800% | 37,143 (+0.77%) | Filing History |
| 2020-10-02 8:58 pm Purchase | 2020-09-17 | 13D | NuCana plc NCNA | Sofinnova Venture Partners VIII L.P. | 321,830 16.600% | 133,333 (+70.74%) | Filing History |
| 2020-02-13 1:38 pm Purchase | 2019-03-05 | 13D | OBSEVA SA COM OBSVF | Sofinnova Venture Partners VIII L.P. | 4,808,486 11.000% | 50,530 (+1.06%) | Filing History |
| 2020-02-13 1:31 pm Purchase | 2019-05-05 | 13D | Natera, Inc. NTRA | Sofinnova Venture Partners VIII L.P. | 3,141,345 4.100% | 18,447 (+0.59%) | Filing History |
| 2020-02-13 1:22 pm Sale | 2019-12-31 | 13G | PRINCIPIA BIOPHARMA INC PRNB | Sofinnova Venture Partners VIII L.P. | 1,438,196 4.400% | -620,950 (-30.16%) | Filing History |